期刊
MATERIALS & DESIGN
卷 216, 期 -, 页码 -出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.matdes.2022.110586
关键词
3D printed prosthetic interface; Autophagy; Osteoporosis; Osseointegration; Rapamycin
资金
- National Key Technologies Research and Development (R&D) Program of China [2018YFB1105100]
- National Natural Science Foundation of China [82001971]
- Jilin Scientific and Technolog-ical Development Program [20200403088SF, 20200802008GH, 20200404202YY, 20200404140YY, 20190304123YY, 20200404190YY, 20180201041SF, 20180623050TC]
- Program of Jilin Provincial Health Depart-ment [2019SCZT001, 2019SCZT014, 2019SRCJ001, 2020SCZT064]
- Youth Talents Promotion Project of Jilin Province [192004]
The study introduces a new therapy combining 3D printed prostheses and transdermal ultrasound-mediated rapamycin delivery to promote osseointegration in an osteoporotic environment. By regulating autophagy levels, cell viability, proliferation, migration, and osteogenesis of osteoporosis-derived bone marrow mesenchymal stem cells (OP-BMSCs) were restored, and potential osteoclast-inducing capacity and adipogenic differentiation were inhibited. The therapy significantly improved bone ingrowth and osseointegration of prosthetic interfaces.
Osteoporosis-derived bone marrow mesenchymal stem cells (OP-BMSCs) have impaired cell function, low osteogenic activity, and potential osteoclast inducibility, resulting in insufficient osseointegration and increased risk of catastrophic postoperative complications after arthroplasty. The low autophagy activity of OP-BMSCs contributed to poor osseointegration, which could be regulated by the classical autophagic activator, rapamycin. Hence, it is of great significance to regulate autophagy by rapamycin to promote osseointegration at the three-dimensional (3D) printed prosthetic interfaces under osteoporotic environment. In this study, 3D printed porous titanium alloy prosthetic interfaces with bionic pore size and porosity were prepared and implanted into the distal femur of osteoporosis rabbits. Subsequently, a transdermal drug delivery device was used to deliver rapamycin to the interfaces implantation sites. Ultrasound-mediated rapamycin delivery could restore the declined cellular activities (including cell viability, proliferation, migration, and osteogenesis), as well as inhibit potential osteoclastinducing capacity and adipogenic differentiation by upregulating the autophagy level of OP-BMSCs. Moreover, percutaneous ultrasound-mediated rapamycin delivery significantly improved bone ingrowth and osseointegration of prosthetic interfaces in osteoporotic environment. To conclude, this novel therapy combining 3D printed bionic prosthesis and percutaneous ultrasound-mediated rapamycin delivery can effectively promote prosthetic interfaces osseointegration by regulating autophagy after arthroplasty for patients with osteoporosis.(c) 2022 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据